Patents by Inventor Scott Stawicki

Scott Stawicki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AND METHODS OF USE
    Publication number: 20240026033
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: March 31, 2023
    Publication date: January 25, 2024
    Applicant: Genentech, Inc.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • ANTIBODIES AND METHODS OF USE
    Publication number: 20220064331
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: June 8, 2021
    Publication date: March 3, 2022
    Applicant: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production
    Patent number: 10882921
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: January 5, 2021
    Assignee: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • ANTIBODIES AND METHODS OF USE
    Publication number: 20190177432
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: February 25, 2019
    Publication date: June 13, 2019
    Applicant: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1
    Patent number: 10246518
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: April 2, 2019
    Assignee: Genentech, Inc.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
    Publication number: 20190016826
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Application
    Filed: September 26, 2018
    Publication date: January 17, 2019
    Inventors: Yan Wu, Menno van Lookeren Campagne, Daniel Kirchhofer, Michael Terry Lipari, Kenneth J. Katschke, JR., Paul M. Moran, Scott Stawicki, Wei-Ching Liang
  • ANTIBODIES AND METHODS OF USE
    Publication number: 20180105605
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 19, 2018
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1
    Patent number: 9884919
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: February 6, 2018
    Assignee: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1
    Patent number: 9873748
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: January 23, 2018
    Assignee: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
    Publication number: 20170342163
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Application
    Filed: July 18, 2017
    Publication date: November 30, 2017
    Inventors: Yan WU, Menno van LOOKEREN CAMPAGNE, Daniel KIRCHHOFER, Michael Terry LIPARI, Kenneth J. KATSCHKE, Jr., Paul M. MORAN, Scott STAWICKI, Wei-Ching LIANG
  • Anti-HtrA1 antibodies and methods of use
    Patent number: 9738727
    Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
    Type: Grant
    Filed: October 12, 2012
    Date of Patent: August 22, 2017
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Menno van Lookeren-Campagne, Daniel Kirchhofer, Michael Terry Lipari, Kenneth J. Katschke, Jr., Paul M. Moran, Scott Stawicki, Wei-Ching Liang
  • Antibodies binding to IL-17A
    Patent number: 9512217
    Abstract: The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: December 6, 2016
    Assignee: GENENTECH, INC.
    Inventors: Yongmei Chen, Yan (Helen) Hu, Wenjun Ouyang, Scott Stawicki, Yan Wu
  • ANTIBODIES AND METHODS OF USE
    Publication number: 20160319038
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: July 19, 2016
    Publication date: November 3, 2016
    Applicant: GENENTECH, INC.
    Inventors: YONGMEI CHEN, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • ANTIBODIES AND METHODS OF USE
    Publication number: 20150218276
    Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
    Type: Application
    Filed: December 23, 2014
    Publication date: August 6, 2015
    Applicant: GENENTECH, INC.
    Inventors: Yongmei Chen, James Ernst, Hok Seon Kim, Junichiro Sonoda, Christoph Spiess, Scott Stawicki, Yan Wu
  • CROSS-REACTIVE AND BISPECIFIC ANTI-IL-17A/F ANTIBODIES
    Publication number: 20140314763
    Abstract: The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.
    Type: Application
    Filed: January 6, 2014
    Publication date: October 23, 2014
    Applicant: Genentech, Inc.
    Inventors: Yongmei Chen, Yan (Helen) Hu, Wenjun Ouyang, Scott Stawicki, Yan Wu
  • Cross-reactive and bispecific anti-IL-17A/F antibodies
    Patent number: 8790642
    Abstract: The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.
    Type: Grant
    Filed: August 26, 2009
    Date of Patent: July 29, 2014
    Assignee: Genentech, Inc.
    Inventors: Yongmei Chen, Yan (Helen) Hu, Wenjun Ouyang, Scott Stawicki, Yan Wu
  • ANTI-ROBO4 ANTIBODIES AND USES THEREFOR
    Publication number: 20110059112
    Abstract: The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.
    Type: Application
    Filed: September 22, 2010
    Publication date: March 10, 2011
    Applicant: Genentech, Inc.
    Inventors: Alexander W. Koch, Scott Stawicki, Yan Wu, Richard Carano, Franklin V. Peale, JR., Ryan J. Watts
  • ANTI-ROBO4 ANTIBODIES AND USES THEREFOR
    Publication number: 20110059013
    Abstract: The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.
    Type: Application
    Filed: September 22, 2010
    Publication date: March 10, 2011
    Applicant: Genentech, Inc.
    Inventors: Alexander W. Koch, Scott Stawicki, Yan Wu, Richard Carano, Franklin V. Peale, JR., Ryan J. Watts
  • Anti-ROBO4 antibodies and uses therefor
    Patent number: 7834154
    Abstract: The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: November 16, 2010
    Assignee: Genentech, Inc.
    Inventors: Alexander W. Koch, Scott Stawicki, Yan Wu, Richard Carano, Franklin V. Peale, Jr., Ryan J. Watts
  • CROSS-REACTIVE AND BISPECIFIC ANTI-IL-17A/F ANTIBODIES
    Publication number: 20100055103
    Abstract: The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.
    Type: Application
    Filed: August 26, 2009
    Publication date: March 4, 2010
    Inventors: YONGMEI CHEN, YAN (HELEN) HU, WENJUN OUYANG, SCOTT STAWICKI, YAN WU